Physician profile
Omar Sheriff
NPI 1023496536
$9,078.18
in general payments reported to CMS, 2019-2025
26 companies · $1,327 in 2025
The $1,327 reported for 2025 was more than what 89% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,304 · 2022: $106 · 2023: $2,317 · 2024: $1,024 · 2025: $1,327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,245 · Education: $1,180 · Consulting Fee: $200 · Gift: $43.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,245.35 |
| Education | $1,179.52 |
| Consulting Fee | $200.00 |
| Gift | $43.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,266.44 | 2021-2025 | Da Vinci Surgical System |
| Body Vision Medical INC. | $1,331.43 | 2023 | Lungvision |
| Pinnacle Biologics, INC | $1,274.67 | 2021 | |
| Glaxosmithkline, LLC. | $521.14 | 2023-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Insmed, INC. | $404.78 | 2023-2025 | Arikayce, Brinsupri |
| Pulmonx Corporation | $344.84 | 2022-2025 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
| Regeneron Healthcare Solutions, INC. | $289.76 | 2023-2025 | Dupixent |
| United Therapeutics Corporation | $257.24 | 2023-2025 | Tyvaso, Tyvaso, Orenitram |
| Boehringer Ingelheim Pharmaceuticals, INC. | $256.94 | 2022-2025 | Ofev, Jascayd |
| Amgen INC. | $174.65 | 2023-2025 | Uplizna, Tezspire |
| Inogen, INC. | $144.67 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Astrazeneca Pharmaceuticals LP | $138.11 | 2024-2025 | Breztri, Airsupra, Imfinzi |
| Galvanize Therapeutics, INC | $123.55 | 2024 | Aliya System |
| Genzyme Corporation | $121.92 | 2024-2025 | |
| Electromed, INC. | $78.75 | 2023-2025 | Smartvest |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $60.28 | 2023 | Fetroja |
| Merck Sharp & Dohme LLC | $52.23 | 2024-2025 | Winrevair, Recarbrio, Zerbaxa |
| Actelion Pharmaceuticals US, INC. | $38.35 | 2022-2025 | Opsumit |
| Ethicon INC. | $35.00 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.77 | 2023 | |
| Inspire Medical Systems, INC. | $26.79 | 2023 | Inspire |
| Janssen Pharmaceuticals, INC | $25.93 | 2024 | Xarelto |
| Verona Pharma, INC. | $24.32 | 2025 | Ohtuvayre |
| Ambu INC. | $19.18 | 2024 | |
| Gilead Sciences, INC. | $16.91 | 2024 | |
| Tactile Systems Technology INC | $15.53 | 2024 | Entre Plus, Flexitouch Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Sheriff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.